Abstract

In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers

Author(s): Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra

Issue: Sep/Oct 2015 - Volume 19, Number 5

Page(s): 432-436

Download in electronic PDF format for $75
  • In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Page 1
  • In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Page 2
  • In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Page 3
  • In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Page 4
  • In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Page 5

Abstract

The objective of this study was to determine in-use stability of ceftaroline fosamil infusion solution of concentrations up to 12 mg/mL in elastomeric home infusion system prefilled with 0.9% Sodium Chloride Injection USP or 5% Dextrose Injection USP and MINI-BAG Plus Container delivery devices prefilled with 0.9% sodium chloride injection. In-use ceftaroline fosamil infusion solution (12 mg/mL) was prepared for elastomeric home infusion systems (Homepump Eclipse, Baxter Intermate, and AccuRx Elastomeric Pump) prefilled with either 0.9% sodium chloride injection or 5% dextrose; or Baxter MINI-BAG Plus Containers pre-filled with 0.9% Sodium Chloride Injection USP (4 mg/mL to 12 mg/mL ceftaroline fosamil in final solution). The systems were stored refrigerated for 24 hours followed by up to 6 hours of storage at room temperature. Samples were analyzed at various time points for assay and degradation product by a validated stability-indicating high-performance liquid chromatography method. In-use ceftaroline fosamil infusion solution, ranging from 4-mg/mL to a maximum of 12-mg/mL concentration, in elastomeric home infusion systems prefilled with 0.9% sodium chloride injection or 5% dextrose, and MINI-BAG Plus Containers prefilled with 0.9% sodium chloride injection were chemically stable for up to 24 hours refrigerated at 2°C to 8°C (36°F to 46°F) and up to 6 hours at room temperature and had acceptable compatibility with material used. Ceftaroline fosamil (4 mg/mL to 12 mg/mL) maintains its potency for up to 24 hours refrigerated at 2°C to 8°C (36°F to 46°F) and up to 6 hours of storage at room temperature upon reconstitution in infusion solution with 0.9% sodium chloride or 5% dextrose when used in elastomeric home infusion system and MINI-BAG Plus Containers delivery devices prefilled with 0.9% sodium chloride injection.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2015
Pg. 432-436
Mar/Apr 2002
Pg. 152-154
May/Jun 2002
Pg. 226-229
May/Jun 2003
Pg. 230-232
May/Jun 2011
Pg. 252-254
Mar/Apr 2011
Pg. 94-100
Author(s): Miron Karen E
Nov/Dec 2019
Pg. 454-461
Sep/Oct 2010
Pg. 436-439
Sep/Oct 2018
Pg. 417-423
Jul/Aug 2016
Pg. 343-346
Sep/Oct 2009
Pg. 386-389
Jul/Aug 2018
Pg. 345-349
Nov/Dec 2014
Pg. 512-515
Jan/Feb 2011
Pg. 6-10
Author(s): Williams LaVonn A
May/Jun 2011
Pg. 183-188
Nov/Dec 2011
Pg. 515-520
Nov/Dec 2003
Pg. 460-463
View Sample
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 149-151
Jan/Feb 2020
Pg. 14-19
Jul/Aug 2021
Pg. 330-335